Bottom line
FIJYX vs VOO: the short answer
FIJYX (Fidelity Advisor Biotechnology Fund) and VOO (Vanguard 500 Index Fund) are both mutual funds.
But VOO is far broader, holding 520 positions to 129 for FIJYX, so beyond the top names it adds exposure FIJYX doesn't have.
VOO is cheaper at 0.03% vs 0.57% — a difference of $54 a year per $10,000 invested.
Over five years, VOO returned +14.4% a year vs +8.1% for FIJYX (reporting dates differ).
Updated Nov 19, 2026
FIJYX vs VOO side by side
| FIJYX | VOO | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | Fidelity | Vanguard |
| Category | Technology Sector | S&P 500 Index |
| Expense ratio | 0.57% | 0.03% |
| Annual cost per $10k | $57 | $3 |
| 10-yr cost on $10k (prospectus) | $714 | $39 |
| Max front load | — | None |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +40.1% | +17.8% |
| 5-yr return (annualized) | +8.1% | +14.4% |
| 10-yr return (annualized) | — | +14.8% |
| Best quarter | +30.3% | +20.5% |
| Worst quarter | −27.8% | −19.6% |
| Net assets (fund) | $2.2B | $1.7T |
| Number of holdings | 129 | 520 |
| Portfolio turnover | 54% | 2% |
| Returns as of | Sep 30, 2026 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
1 of FIJYX's top 25 holdings also appear in VOO's top 25.
| Holding | FIJYX | VOO |
|---|---|---|
| Abbvie Inc | 14.71% | 0.69% |
Source: SEC Form N-PORT
FIJYX top 10
- Abbvie Inc — 14.71%
- Gilead Sciences Inc — 5.70%
- Spyre Therapeutics Inc — 3.83%
- Alnylam Pharmaceuticals Inc — 3.62%
- Dianthus Therapeutics Inc — 3.55%
- Cogent Biosciences Inc — 3.25%
- Oruka Therapeutics Inc — 3.24%
- Insmed Inc — 3.05%
- Revolution Medicines Inc — 3.00%
- Argenx Se — 3.00%
VOO top 10
- NVIDIA Corp — 7.51%
- Apple Inc — 6.59%
- Microsoft Corp — 4.30%
- Amazon.com Inc — 3.62%
- Alphabet Inc — 3.25%
- Broadcom Inc — 2.77%
- Alphabet Inc — 2.59%
- Micron Technology Inc — 2.02%
- Meta Platforms Inc — 1.92%
- Tesla Inc — 1.84%
FAQ
What is the difference between FIJYX and VOO?
Which is cheaper, FIJYX or VOO?
Should I own both FIJYX and VOO?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.